This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS
Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. BJS 2001; 88: 31-40.
Published: 6th December 2002
Authors: G. D. Slooter, A. Mearadji, W. A. P. Breeman, R. L. Marquet, M. de Jong, E. P. Krenning et al.
Background
Somatostatin receptors have been found on a variety of neuroendocrine tumours, such as carcinoids and paragangliomas, as well as on most pancreatic endocrine and breast tumours. Somatostatin receptor scintigraphy with a radionuclide‐labelled somatostatin analogue, [111Indium‐diethylenetriaminopenta‐acetic acid]octreotide, is a sensitive and specific technique for visualizing in vivo the presence of somatostatin receptors on various tumours.
Method
Material was identified from previous review articles, references cited in original papers and a Medline search of the literature. Additional material was obtained from recently published abstracts of meetings.